PURIFICATION AND CLONING OF NMN ADENYLYLTRANSERASE AND ITS THERAPEUTIC USE
Details for Australian Patent Application No. 2003220201 (hide)
Event Publications
31 July 2003 Complete Application Filed
Priority application(s): 60/368,078 26.03.02 US
20 November 2003 Application Open to Public Inspection
Published as AU-A-2003220201
16 December 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003220202-N3 alkylated benzimidazole derivatives as MEK inhibitors
2003220200-IMPROVING THE EFFICIENCY OF POWER AMPLIFIERS IN DEVICES USING TRANSMIT BEAMFORMING
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser